அனிதா ரமேஷ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அனிதா ரமேஷ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அனிதா ரமேஷ் Today - Breaking & Trending Today

Tamil Nadu's first SARS-CoV-2 antibody cocktail treatment for COVID-19 begins at Kauvery Hospital


Tamil Nadu s first SARS-CoV-2 antibody cocktail treatment for COVID-19 begins at Kauvery Hospital
ANI |
Updated: May 28, 2021 18:14 IST
Chennai (Tamil Nadu) [India], May 28 (ANI/NewsVoir): A new entrant into the treatment portfolio of COVID-19 in India is the cocktail formulation of Mono Clonal Antibodies (MCAb).
This treatment is offered to patients early in the evolution of COVID, in the phase of active multiplication of the virus in the body. That is invariably within ten days of the onset of the earliest symptoms of COVID-19. This timely intervention can reduce or even avoid the need for hospitalization by 70 percent.
Kauvery Hospital, one of the leading healthcare chains in Tamil Nadu, has kick started the antibody cocktail treatment. A COVID-19 patient with mild symptoms has already been the first to receive this treatment. The individual was cancer patient with newly diagnosed of early onset of renal failure, and the ....

Tamil Nadu , Aravindan Selvaraj , Anita Ramesh , Mono Clonal Antibodies , Prof Dr Anita Ramesh , Senior Consultant , Medical Oncology , Kauvery Hospital Chennai , Executive Director , Kauvery Hospital , Dr Aravindan Selvaraj , தமிழ் நாடு , அரவிந்தன் செல்வராஜ் , அனிதா ரமேஷ் , மூத்தவர் ஆலோசகர் , மருத்துவ புற்றுநோயியல் , கௌஊவேறி மருத்துவமனை சென்னை , நிர்வாகி இயக்குனர் , கௌஊவேறி மருத்துவமனை ,

Hospital begins monoclonal antibody treatment


Hospital begins monoclonal antibody treatment
Updated:
Updated:
Drug is said to bring down hospitalisation by 70%
Share Article
Drug is said to bring down hospitalisation by 70%
Kauvery Hospital in Chennai has treated a mildly symptomatic but high-risk COVID-19 patient with the monoclonal antibody cocktail that has been approved for emergency use in India. A statement issued by the hospital claimed that this was the first time the treatment had been used by a hospital in Tamil Nadu.
The individual was a cancer patient, who was recently diagnosed with early onset of renal failure, and hence was at higher risk of developing severe complications due to COVID-19. ....

Tamil Nadu , Aravindan Selvaraj , Anita Ramesh , Central Drugs Standards Control Organisation Of India , Kauvery Hospital , Switzerland Based Roche , Central Drugs Standards Control Organisation , Emergency Use Authorisation , தமிழ் நாடு , அரவிந்தன் செல்வராஜ் , அனிதா ரமேஷ் , கௌஊவேறி மருத்துவமனை , சுவிட்சர்லாந்து அடிப்படையிலானது ரோச் , மைய மருந்துகள் தரநிலைகள் கட்டுப்பாடு ஆர்கநைஸேஶந் ,